All In Biotech

Free tool

FAERS Monitor: Pepcid Ac

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020325 or its brand name (Pepcid Ac, Famotidine). Reports on generic versions are filed under their own applications.

Reports

84,762

Serious

56,219

66% of reports

Hospitalization

28,101

Death reported

8,065

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea5,480
  • fatigue5,226
  • diarrhoea5,095
  • chronic kidney disease4,686
  • off label use4,432
  • drug ineffective4,253
  • dyspnoea4,008
  • headache3,755
  • acute kidney injury3,418
  • vomiting3,320
  • pain3,257
  • dizziness3,157
  • death2,857
  • pneumonia2,735
  • pyrexia2,668

Reports by year received

View as table
YearReports
2004743
2005736
2006692
2007679
2008850
2009721
20101,023
20111,563
20121,933
20131,154
20141,431
20152,552
20163,020
20173,301
20184,644
20195,538
20206,658
20216,825
20227,306
20237,406
20248,625
20259,592
20267,766

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,969,397 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic kidney diseaseSignal4,68616.215.863,114
acute kidney injurySignal3,4185.65.512,865
pneumoniaSignal2,7352.12.01,598
diarrhoea5,0952.01.92,475
pyrexia2,6681.91.81,186
dyspnoea4,0081.81.71,348
vomiting3,3201.81.71,100
nausea5,4801.71.71,715
fatigue5,2261.71.61,449
dizziness3,1571.61.5673
headache3,7551.51.4618
pain3,2571.31.3255
off label use4,4321.31.2242
death2,8570.80.8114
drug ineffective4,2530.80.8226

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.